PMDA inspection

Novo Nordisk Pharmaceutical Industries, LP

PMDA inspection 5130508031007 · USA · Suitable

Key facts

Control number 5130508031007
Manufacturing site Novo Nordisk Pharmaceutical Industries, LP
Location 3612 Powhatan Road Clayton North Carolina 27527, USA
Country USA
Product type Pharmaceuticals
Application type Complete Change
Inspection method Remote
Inspection month Feb 1, 2024
Result Suitable
Result notified Feb 8, 2024
PMDA registration AG30400142

About PMDA GMP inspections (Japan)

Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Browse all PMDA GMP inspections (Japan)